CIK 0000860730 · Large accelerated filer
HCA Healthcare, Inc.
Sign in to watch- Ticker
- HCA
- Exchange
- NYSE
- Industry
- Services-General Medical & Surgical Hospitals, NEC
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 273865930
- Phone
- 6153449551
- Business address
- ONE PARK PLZ, NASHVILLE, TN, 37203
- Former names
- HCA Holdings, Inc., HCA INC/TN, HCA THE HEALTHCARE CO, HCA-THE HEALTHCARE CO, COLUMBIA HCA HEALTHCARE CORP, COLUMBIA HCA HEALTHCARE CORP/, COLUMBIA HEALTHCARE CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $18,251,400
- in 3 filings
Net −$18,251,400. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-11-12 | Akdamar Erol R Group President | Shares withheld for taxes | −10,257 | $350.53 | $3.6M | 9,743 |
| 2024-11-12 | Akdamar Erol R Group President | Option exercise · Stock Appreciation Right | −20,000 | 0 | ||
| 2024-11-11 | Whalen Kathleen M SVP & Chief Ethics Officer | Option exercise | +4,710 | $173.12 | $815K | 14,164 |
| 2024-11-11 | Whalen Kathleen M SVP & Chief Ethics Officer | Shares withheld for taxes | −3,236 | $357.99 | $1.2M | 10,928 |
| 2024-11-11 | Whalen Kathleen M SVP & Chief Ethics Officer | Option exercise · Stock Appreciation Right | −4,710 | 1,570 | ||
| 2024-10-30 | Elcan Patricia F 10% owner | Other disposition | −244,626.04 | $361.55 | $88.4M | 404,512.1 |
| 2024-10-30 | Elcan Patricia F 10% owner | Other disposition | −138,000 | $361.55 | $49.9M | 638,573.96 |
| 2024-10-30 | Elcan Patricia F 10% owner | Other disposition | −638,573.96 | $361.55 | $230.9M | 0 |
| 2024-10-30 | Elcan Patricia F 10% owner | Other acquisition | +138,000 | $361.55 | $49.9M | 264,216.92 |
| 2024-10-30 | Elcan Patricia F 10% owner | Other acquisition | +244,626.04 | $361.55 | $88.4M | 9,029,962.4 |
| 2024-10-30 | Elcan Patricia F 10% owner | Other acquisition | +638,573.96 | $361.55 | $230.9M | 9,668,536.36 |
| 2024-09-12 | Cuffe Michael S. EVP and Chief Clinical Officer | Sale 10b5-1 | −8,358 | $385.42 | $3.2M | 29,678.21 |
| 2024-09-10 | Cuffe Michael S. EVP and Chief Clinical Officer | Option exercise 10b5-1 | +22,080 | $145.24 | $3.2M | 51,758.21 |
| 2024-09-10 | Cuffe Michael S. EVP and Chief Clinical Officer | Shares withheld for taxes 10b5-1 | −13,722 | $386.43 | $5.3M | 38,036.21 |
| 2024-09-10 | Cuffe Michael S. EVP and Chief Clinical Officer | Option exercise · Stock Appreciation Right 10b5-1 | −22,080 | 0 | ||
| 2024-08-08 | Marks Mike A EVP and CFO | Gift | −2,237 | 0 | ||
| 2024-08-08 | Marks Mike A EVP and CFO | Gift | +2,237 | 43,227 | ||
| 2024-08-08 | HAZEN SAMUEL N CEO | Gift | −7,115 | 0 | ||
| 2024-08-08 | HAZEN SAMUEL N CEO | Gift | +7,115 | 14,979 | ||
| 2024-08-06 | HAZEN SAMUEL N CEO | Gift | −7,115 | 78,296 |
Page 11 of 56 · 1,102 trades